Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: a meta-analysis and system review

BACKGROUND: Our study aimed to verify the prognostic value of circulating tumor cells (CTCs) prior to initial treatment on survival of non-small cell lung cancer (NSCLC) by using meta-analysis and system review of published studies. MATERIALS AND METHODS: The PubMed, EMBASE and Cochrane Library were...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Sha-Sha, Deng, Bo, Feng, Yong-Geng, Qian, Kai, Tan, Qun-You, Wang, Ru-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933689/
https://www.ncbi.nlm.nih.gov/pubmed/31878900
http://dx.doi.org/10.1186/s12890-019-1029-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933689/
https://www.ncbi.nlm.nih.gov/pubmed/31878900
http://dx.doi.org/10.1186/s12890-019-1029-x

Ejemplares similares